On Demand 2024 Sunday AM General Sessions

This collection covers general sessions from Sunday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:

  • Plenary: Practical Drug Allergy
  • Introductory Course in Rhinolaryngoscopy
  • 7 for 11: Hot Topics in Pediatrics A&I -- A Joint Presentation from AAP-SOAI & ACAAI
  • Coding and Government Relations
  • Practical Toolkits for Your Food Allergy Clinic: Tackling Anxiety, Proximity and Infant OFCs and Dietary Issues
  • Difficult to Manage Rhinitis/ Sinusitis

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Appraise risks and benefits of beta lactam challenges in the clinic.
  • Develop a protocol for desensitization to biologics and chemotherapeutic agents.
  • Identify immune checkpoint inhibitors and the type of adverse drug reactions they typically cause.
  • Describe the major anatomical findings in the upper airway.
  • Identify normal and abnormal anatomy, disease presentations and post-op findings.
  • Appraise indications for use of the rhinoscope in the allergist’s office.
  • Compare new diagnosis and treatments for food allergy.
  • Identify updates in pediatric asthma and allergy.
  • Recognize changes in diagnosis and management of pediatric skin and immune disorders.
  • Utilize ICD10 Coding through cased based approach.
  • Detail current issues from payors and CMS faced by allergist.
  • Trace government issues on Capitol Hill.
  • Identify and manage anxiety in the context of food allergy.
  • Perform proximity challenges and how to identify the right candidate for these.
  • Support Infant OFCs and describe existing protocols. Address growth problems in the food allergy clinic.
  • Review the pathogenesis, diagnosis, and treatment of local allergic rhinitis.
  • Identify medical and surgical management strategies for CRSwNP, including treatment options for AERD patients who do not respond to first-line therapy.
  • Design treatment options, with a focus on biologics and aspirin desensitization, for AERD patients who do not respond to first-line therapy.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.
Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 Attendance
  • 7.50 CBRN
Course opens: 
11/11/2024
Course expires: 
11/10/2027
Part of: 
On Demand ACAAI 2024 Annual Scientific Meeting General Sessions
Rating: 
0

Kristin C. Sokol, MD, FACAAI
Cosby A. Stone, Jr., MD
John M. Kelso, MD, FACAAI
Mariana C. Castells, MD, PhD, FACAAI
Kimberly G. Blumenthal, MD, MSc, FACAAI
Jerald W. Koepke, MD, FACAAI
Seong H. Cho, MD, FACAAI
Todd A. Mahr, MD, FACAAI
Angela D. Hogan, MD, FACAAI
Theresa A. Bingemann, MD, FACAAI
J. Andrew Bird, MD, FACAAI
Eric M. Schauberger, DO, PhD, FACAAI
Julie Wang, MD, FACAAI
Vivian P. Hernandez-Trujillo, MD, FACAAI
Ama Alexis, MD, FACAAI
J. Wesley Sublett, MD, MPH, FACAAI
Lara M. Gross, MD
Gary N. Gross, MD, FACAAI
Travis A. Miller, MD, FACAAI
Matt Reiter
S. Shahzad Mustafa, MD, FACAAI
Stefania Arasi, MD, PhD, MSc
Jennifer S. LeBovidge, PhD
Jonathan O'B Hourihane, MD
Aikaterini Anagnostou, MD, PhD, FACAAI
Carina Venter, PhD, RD
Daniel Ein, MD, FACAAI
Nancy I. Joseph, DO, FACAAI
Anju T. Peters, MD
Joseph K. Han, MD

Available Credit

  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 Attendance
  • 7.50 CBRN
Please login or create an account to take this course.